Erlotinib is a Human Epidermal Growth Factor Receptor Type 1/Epidermal Growth Factor Receptor (HER1/EGFR) tyrosine kinase inhibitor. It is marketed as Tarceva for the treatment of locally advanced or metastatic non-small cell lung cancer or pancreatic cancer.

Related categories 1

RxList: Tarceva (Erlotinib)
Provides the medication description and drug information including side effects, interactions and patient labeling.
Tarceva (Erlotinib)
Advanced non-small cell lung cancer and advanced pancreatic cancer information. Official site from Genentech and OSI Pharmaceuticals.
[Eye Mozilla]
Last update:
April 20, 2008 at 18:45:49 UTC
Health
Home
News
Recreation
Reference
Regional
Science
Shopping
Society
Sports
All Languages
Arts
Business
Computers
Games